Search Results
Aug 19, 2025, 09:00 ET 10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis
Calif., Aug. 19, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Xenium Protein, a powerful new addition to its Xenium Spatial platform that
More news about: 10x Genomics, Inc.
Aug 07, 2025, 16:05 ET 10x Genomics Reports Second Quarter 2025 Financial Results
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended June 30, 2025.
More news about: 10x Genomics, Inc.
Aug 07, 2025, 16:04 ET 10x Genomics to Acquire Scale Biosciences
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has signed a definitive agreement to acquire Scale Biosciences, Inc., a leader
More news about: 10x Genomics, Inc.
Jul 17, 2025, 09:00 ET 10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GIS), today announced
More news about: 10x Genomics, Inc.
Jul 10, 2025, 16:05 ET 10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the second quarter ended June 30,
More news about: 10x Genomics, Inc.